Home › Bids
› Forecast to Publish a Notice of Funding Opportunity for SBIR
Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
This is a forecast for a Notice of Funding Opportunity (NOFO) for SBIR Phase IIB Bridge Awards. The goal is to accelerate the development and commercialization of cancer-relevant technologies, with an optional clinical trial component. The funding opportunity number is FOR-CA-25-086 and the CFDA numbers are 93.395 and 93.394.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
SBIR Phase IIB Bridge Award Funding for Cancer Technology Development
1
each
$1,500,000.00
$1,500,000.00
Medical
Optional Clinical Trial Services
1
each
—
—
Medical
Estimated Bid Value
$1,500,000.00
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.